A naukri.com initiative
Bioengineer
1d
328
Image Credit: Bioengineer
Promising Outcomes from NHS PROGRESS Study Highlight the Integration of Pharmacogenomic-Guided Prescribing into Routine Clinical Practice
- A pioneering study in Milan, Italy, is leading the way in integrating pharmacogenomics into routine clinical practice to optimize treatment efficacy and minimize adverse effects.
- Dr. John McDermott's team at the NHS-England Network of Excellence for Pharmacogenomics & Medicines Optimisation has developed a framework to seamlessly incorporate patients' genomic data into electronic health records for better medication choices.
- Pharmacogenomics stands out for its lifelong relevance, influencing drug metabolism and efficacy each time a new prescription is considered, presenting a challenge due to clinicians' lack of formal training in interpreting genetic data.
- The innovative informatics approach by McDermott's team delivers actionable prescribing recommendations within existing electronic health record systems, making genomic information more accessible to clinicians.
- The NHS PROGRESS programme involves a multicenter study focusing on patients prescribed common drugs, with initial findings showing that actionable pharmacogenomic variants impacted medication choices for a significant number of participants.
- Pharmacogenomics interventions like those in the study require robust cost-effectiveness data to demonstrate their value, with evidence supporting the financial and clinical benefits of genomic testing in certain contexts.
- The study aims to quantify the downstream impacts of pharmacogenomic prescribing on healthcare utilization and costs to bolster the case for national adoption of these strategies and transform prescribing norms.
- Clinicians have demonstrated high adherence to pharmacogenomic guidance, incorporating genetic data into treatment decisions seamlessly, indicating the potential for pharmacogenomic profiles to become routine in medical records globally.
- The success of integrating pharmacogenomic data into routine care signals a shift towards personalized medicine where each prescription is tailored to the patient's unique genetic makeup, enhancing therapeutic benefits and minimizing risks.
- The NHS PROGRESS study showcases how the intersection of genomics, informatics, and clinical practice can improve patient care by optimizing medication safety and effectiveness through pharmacogenomics.
- As pharmacogenomics becomes more integrated into healthcare workflows, it paves the way for a future where genetics play a crucial role in guiding treatment decisions, ushering in a new era of truly personalized medicine.
Read Full Article
19 Likes
For uninterrupted reading, download the app